Leon Hooftman
Chief Medical Officer · Barinthus Biotherapeutics plc.
Individual
- 2026
- Sep 9, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Leon Hooftman's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Ronda E. Stryker - $580.89M in SYK purchases and sales in the last 12 months
- Mozart Aggregator II LP - $579.20M in MDLN purchases and sales in the last 12 months
- TC Group VII S1, L.L.C. - $554.95M in MDLN purchases and sales in the last 12 months
- BERKSHIRE HATHAWAY INC - $488.34M in DVA purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $430.69M in PBLS purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $399.66M in SYRE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Leon Hooftman?
Leon Hooftman is a corporate insider, tracked as Chief Medical Officer of Barinthus Biotherapeutics plc. (BRNS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Leon Hooftman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
